Senior editor Irene Jarchum talks to Cliona Rooney about a recent paper in which Mark Cobbold and colleagues describe an antibody-mediated strategy to retarget virus-specific T cells against tumors. The paper was published in Nature Biotechnology; it can be read at https://doi.org/10.1038/s41587-019-0404-8.
About this article
Cite this article
Forum: Repurposing viral immunity to fight cancer. Nat Biotechnol 38, 419 (2020). https://doi.org/10.1038/s41587-020-0474-7